Ono Pharmaceutical Co. Lt... (OPHLY)
4.00
-0.15 (-3.61%)
At close: Apr 22, 2025, 3:59 PM
-3.61% (1D)
| Bid | 4 |
| Market Cap | 5.64B |
| Revenue (ttm) | 500.33B |
| Net Income (ttm) | 120.95B |
| EPS (ttm) | 0.37 |
| PE Ratio (ttm) | 10.81 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 4.06 |
| Volume | 18,551 |
| Avg. Volume (20D) | 426,864.6 |
| Open | 4.21 |
| Previous Close | 4.15 |
| Day's Range | 4.00 - 4.21 |
| 52-Week Range | 3.21 - 5.20 |
| Beta | 0.44 |
About OPHLY
Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers OPDIVO intravenous infusions for the treatment of malignant tumors; KYPROLIS for intravenous injection; EMEND capsules/PROEMEND intravenous injections for chemotherapy-induced nausea and vomiting; DEMSER capsules for improvement of the symptoms in patients with pheochromocytoma; and MEKTOVI, VEL...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Oct 2, 2012
Employees 3,853
Stock Exchange PNK
Ticker Symbol OPHLY
Website https://www.ono-pharma.com